* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Meibang Pharmaceutical Group Co OCF Margin % Chart
Shaanxi Meibang Pharmaceutical Group Co Annual Data
SHSE:605033 vs CTVA, CF, MOS: OCF Margin % Comparison
For the Agricultural Inputs subindustry, Shaanxi Meibang Pharmaceutical Group Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shaanxi Meibang Pharmaceutical Group Co OCF Margin % vs Agriculture Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a OCF Margin % of -44.23% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. According to the industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #28 out of 248 companies in the Agriculture industry, placing it in the top 11.3%.
Is Shaanxi Meibang Pharmaceutical Group Co's OCF Margin % too high?
Shaanxi Meibang Pharmaceutical Group Co's current OCF Margin % is -44.23%. Based on the distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #28 out of 248 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's OCF Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #28 out of 248 companies for OCF Margin %. This places Shaanxi Meibang Pharmaceutical Group Co in the top 11% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 4.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for an Agriculture company?
The median OCF Margin % among Agriculture companies is 4.70, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. For the Agriculture industry, the median OCF Margin % is 4.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Meibang Pharmaceutical Group Co's current OCF Margin % is -44.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.13, compared to a current price of ¥17.37 — trading 21.5% below its estimated fair value. The current OCF Margin % is -44.23%. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current OCF Margin % is -44.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥17.37 is trading 21.5% below its estimated GF Value™ of ¥22.13.
GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:605033:
OCF Margin %: -44.23%
GF Value™: ¥22.13 vs. price of ¥17.37 (21.5% below fair value)
No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shaanxi Meibang Pharmaceutical Group Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605033 has been successfully added to your 
